World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21432
World Ranking
17627
National Ranking
588

Overview

Odile Oberlin is affiliated with the Institut Gustave Roussy in France and works primarily in the field of Medicine with a focus on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine, Sociology and Political Science, and Molecular Biology.

The scientist's research centers on several key topics, including:

  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Family Support in Illness
  • Renal and related cancers
  • Advances in Oncology and Radiotherapy
  • Radiation Therapy and Dosimetry
  • Adolescent and Pediatric Healthcare

Oberlin has contributed to publications across several journals, notably:

  • Pediatric Blood & Cancer
  • Cancer Epidemiology Biomarkers & Prevention
  • Psycho-Oncology
  • Journal of Clinical Oncology
  • Progrès en Urologie - FMC

Some recent papers by Oberlin with publication year and venue include:

  • Smoking and Cannabis Use among Childhood Cancer Survivors: Results of the French Childhood Cancer Survivor Study, 2021, Cancer Epidemiology Biomarkers & Prevention
  • The development of an international childhood cancer hospital register database in 13 African countries. A project of the French African Pediatric Oncology Group (GFAOP), 2021, Pediatric Blood & Cancer
  • Establishing a pediatric radiation oncology department in a low- and middle-income country: Major challenge in implementing the Global Initiative for Childhood Cancer, 2021, Pediatric Blood & Cancer
  • Identifying clusters of health risk behaviors and their predictors in adult survivors of childhood cancer: A report from the French Childhood Cancer Survivor Study, 2020, Psycho-Oncology
  • Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study, 2025, Journal of Clinical Oncology

Frequent collaborators in Oberlin's research include:

  • Brice Fresneau
  • Sandrine Pinto
  • Aurélie Mayet
  • F Pein
  • Imène Mansouri

Best Publications

  • Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease

    Smita Bhatia;Leslie L. Robison;Odile Oberlin;Mark Greenberg

  • High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group

    Smita Bhatia;Yutaka Yasui;Leslie L. Robison;Jillian M. Birch

  • Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Nathalie Gaspar;Douglas S. Hawkins;Uta Dirksen;Ian J. Lewis

  • Second malignant neoplasms in children: an update from the Late Effects Study Group.

    A T Meadows;E Baum;F Fossati-Bellani;D Green

  • Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

    Ruth Ladenstein;Ulrike Pötschger;Marie Cécile Le Deley;Jeremy Whelan

  • Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer

    Markhaba Tukenova;Catherine Guibout;Odile Oberlin;Françoise Doyon

  • Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

    Franck Tirode;Didier Surdez;Xiaotu Ma;Matthew Parker

  • Fusion Gene-Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

    Daniel Williamson;Edoardo Missiaglia;Aurélien de Reyniès;Gaëlle Pierron

  • Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

    Odile Oberlin;Annie Rey;Elizabeth Lyden;Gianni Bisogno

  • Leukemia After Therapy With Alkylating Agents for Childhood Cancer

    Margaret A. Tucker;Anna T. Meadows;John D. Boice;Marilyn Stovall

  • Treatment of Nonmetastatic Rhabdomyosarcoma in Childhood and Adolescence: Third Study of the International Society of Paediatric Oncology—SIOP Malignant Mesenchymal Tumor 89

    Michael C.G. Stevens;Annie Rey;Nathalie Bouvet;Caroline Ellershaw

  • Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation

    Sébastien Salas;Armelle Dufresne;Binh Bui;Jean-Yves Blay

  • Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial

    Christine Juergens;Claire Weston;Ian J. Lewis;Jeremy Whelan

  • PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

    Edoardo Missiaglia;Dan Williamson;Julia Chisholm;Pratyaksha Wirapati

  • Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients.

    S. Bonvalot;H. Eldweny;V. Haddad;F. Rimareix

  • Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study

    Florent de Vathaire;Florent de Vathaire;Florent de Vathaire;Chiraz El-Fayech;Chiraz El-Fayech;Chiraz El-Fayech;Faten Fedhila Ben Ayed;Nadia Haddy;Nadia Haddy;Nadia Haddy

  • Infantile Fibrosarcoma: Management Based on the European Experience

    Daniel Orbach;Annie Rey;Giovanni Cecchetto;Odile Oberlin

  • Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial

    Marie-Cecile Le Deley;Olivier Delattre;Karl-Ludwig Schaefer;Sue A. Burchill

  • Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.

    Gudrun Schleiermacher;Martine Peter;Odile Oberlin;Thierry Philip

  • Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84

    F. Flamant;C. Rodary;A. Rey;M.-T. Praquin

Frequent Co-Authors

Jean Michon
Jean Michon Institute Curie
Michael C. Stevens
Michael C. Stevens Yale University
Olivier Delattre
Olivier Delattre PSL University
Laurence Brugières
Laurence Brugières Institut Gustave Roussy
Christine Haie-Meder
Christine Haie-Meder Institut Gustave Roussy
Gilles Vassal
Gilles Vassal Institut Gustave Roussy
Janet Shipley
Janet Shipley Institute of Cancer Research
Ian Judson
Ian Judson Institute of Cancer Research
Alan W. Craft
Alan W. Craft Newcastle University
Kathy Pritchard-Jones
Kathy Pritchard-Jones University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn’t just mean traditional medical school. There are several related online degrees and alternative career pathways in healthcare that offer flexibility and accessibility while preparing you for in-demand roles.

For example, advancing your expertise in health records or hospital systems is possible through an online MHI program. These degrees prepare graduates for leadership positions in healthcare information management.

If you’re interested in supporting medical offices, medical billing and coding online courses cost less than you might expect and can be a fast track into administrative healthcare roles.

For those pursuing clinical practice, becoming a nurse practitioner is an excellent path. The cheapest NP school options offer accredited graduate programs online at affordable rates, allowing RNs to advance their career remotely.

Even entry-level nursing can be accessible through cheapest online nursing programs, which deliver reputable instruction and open doors within the healthcare workforce.

Each pathway offers unique benefits and entry points, helping you find the right fit for your goals in medicine or healthcare in the USA.

Best Scientists Citing Odile Oberlin

Trending Scientists